欧冠升:首季ETF日均成交金额较去年全年增加逾30%
港交所(00388.HK)行政总裁欧冠升表示,沪港互挂ETF产品首次在本港及上海两地同时上市为两地交易所紧密合作的成果,现时有更多环球投资者开始透过ETF捕捉亚洲市场增长机遇,国际投资者亦可透过本港及内地ETF互挂计划涉足内地市场投资主题,亦可为国际ETF发行商提供接触中国投资者的途径。他指,亚洲投资者亦日益使用ETF构建其国际投资组合,提升其投资组合的多样性及覆盖范围。
他又指,港交所致力发展亚洲ETF市场,中国新经济主题产品数量不断增加,首季日均成交金额更较去年全年增加逾30%。他指,期待日後与内地交易所、两地监管机构及市场各方合作,提供更多投资机遇,并进一步优化ETF互挂计划。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.